SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?


To: DavidCG who wrote (26399)12/11/1998 12:26:00 PM
From: Ernest Poe  Read Replies (1) | Respond to of 119973
 
tctv. Looking good....breaking new day highs.



To: DavidCG who wrote (26399)12/11/1998 12:28:00 PM
From: brent gephart  Read Replies (3) | Respond to of 119973
 
Look if you want to day trade CRII that is fine, I'm just saying it is not as clear cut as you are making it and their is a 500 pound gorilla out there call B&D. Frankly, I want CRII to succeed because B&D will then move head with its plans to bring JMAR's Lightknife to market which will go right into the hands of the hospitals and doctors.

Brent



To: DavidCG who wrote (26399)12/11/1998 12:59:00 PM
From: MARK C.  Read Replies (2) | Respond to of 119973
 
David, I have been around diabetics my entire life and I fail to see how the LASSETTE will be anything other than a niche market.
1. They are way to expensive unless they can cut the price down to (my guess the 300 dollar mark)
2. What is the cost of the test strips needed to read the glucose levels. This is the most expensive part of current lancet testing. 100 strips run about 70-75 dollars.
3. Your argument that parents will want it because it does not cause their children pain is valid to some degree , however the largest percentage of diabetics are not children they are aging adults who have pain tolerance enough to put up with a pin prick when the alternative runs $2,000 plus the yet unknown cost of the test strips.
4.Several companies are developing non invasive glucose testing using such things as light. If they get the FDA to ease up the requirements for PMA testing they will be available in a couple years. IMHO this is a step in the right direction but I don't think they have a chance in hell of capturing even a half a percent of the Glucose monitoring business. I can't imagine insurance companies authorizing payments of $2,000 plus per patient when they can get away with a fraction of that price per patient using traditional lancettes, Can you?